Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
Date:2/10/2011

lment for the double-blind studies in the first quarter of 2011 and reporting top-line results in the first half of 2012.

TESTIM:

  • Worldwide revenues for Testim were $193.0 million for the year ending December 31, 2010, up 20% over 2009.
  • Testim U.S. revenues were up 25% over the prior year to a record $190.0 million.
  • Testim U.S. prescriptions in the fourth quarter of 2010 grew by 10% over the fourth quarter of 2009 to approximately 180,000 according to National Prescription Audit data from IMS Health, Inc. (IMS), a leading market research firm.
  • Total prescriptions for the testosterone replacement gel market segment grew 12% in the fourth quarter of 2010 versus the same period in 2009, according to data from IMS.
  • In October, 2010, the U.S. Food and Drug Administration (FDA) issued a response to the Citizen Petition submitted on behalf of Abbott Laboratories regarding testosterone gel products.  In its response, FDA stated that an application for a potential generic testosterone gel with a different penetration enhancer than the originator must be submitted as a 505(b)(2) New Drug Application (NDA) rather than an Abbreviated New Drug Application.  FDA further stated that the NDA would be treated as a separate application requiring independent patent certification and notification and would be clocked for regulatory purposes from the time it is provided, resulting potentially in a new 30-month stay.

  • 2011 Financial Guidance and Strategic PrioritiesFor 2011, Auxilium anticipates that:

  • XIAFLEX revenues will be in the range of $55 million to $67 million;
  • Testim revenues will be in the range of $200 million to $210 million;
  • Research and development spending will be in the range of $60 million to $70 million;
  • Selling, general and administrative expenses will be in the range of $170 million to $180 million;
  • Net loss will be in the range of $35 million to
    '/>"/>

  • SOURCE Auxilium Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
    2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
    3. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
    4. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
    5. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
    6. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
    7. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
    8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
    9. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
    10. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
    11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/22/2014)... DIEGO , Dec. 22, 2014 GenomeDx ... the Decipher Prostate Cancer Classifier, a genomic test for ... in node-negative, high-risk men managed by radical prostatectomy without ... radical prostatectomy is relatively uncommon, using tumor genomics to ... of metastatic disease is an important advance. The study ...
    (Date:12/22/2014)... ITRA Global, one of the largest ... real estate, has further expanded its global reach with ... Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman of ... Global / ACORPP (Australian Corporate Property and Projects) , ... property services to a wide range of clients in ...
    (Date:12/19/2014)... MA (PRWEB) December 19, 2014 Charm ... MRLAFMQ test for the Detection of Aflatoxin M1 in ... to receive independent third party validation. The peer reviewed ... Unit of the Institute for Agricultural and Fisheries Research ... Group. , Aflatoxin B1, the most toxic aflatoxin ...
    (Date:12/19/2014)... Calif. , Dec. 19, 2014  Roche (SIX: ... of Bina Technologies, Inc. (Bina), a privately held ... , USA. Bina provides a big data ... generation sequencing (NGS) data. Bina,s proprietary on-market Genomic ... and academic researchers to perform fast and scalable ...
    Breaking Biology Technology:Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3
    ... Wis. - While human stem cells offer potential therapeutic ... more immediate benefit from research into such cells will likely ... area that for many years has been steeped in the ... since disease works within the context of cells. , ,But, ...
    ... La Crosse, Wis. - Healthcare professionals will have the ... implications upon the profession at the Wisconsin Dairyland HIMSS ... Sept. 12-13 at the Radisson hotel in La Crosse, will ... dedicated to social events such as a golf outing and ...
    ... Wis. - The Tascon Group has launched the Tascon ... analysis and job costing. , ,The Business Analyst is being ... www.thebusinessanalyst.com . , ,The program is based on a ... the 1980s - a system known as the optimization method. ...
    Cached Biology Technology:Human stem cells called great opportunity for drug discovery 2Human stem cells called great opportunity for drug discovery 3Conference will review healthcare IT 2
    (Date:12/22/2014)... 2014  The 2014 Holiday Season may be ... Acuity Market Intelligence reports that the long anticipated ... Acuity forecasts that intensifying demand for smart phones, ... will drive a global market of 2.5 billion ... 2020.   According to Maxine ...
    (Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research ... announced the addition of the "Samsung Galaxy ... Analysis" report to their offering. ... on a totally different sensing technology than the ... a fingerprint sensor in its product. ...
    (Date:12/17/2014)... -- Automation is fundamentally transforming the travel experience and ... borders. Over the past decade, ePassports, biometric readers, ... to self process through border control via eGates ... increasing number of airports, seaports, and land borders ... Maxine Most , Principal at Acuity Market ...
    Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
    ... this latest image acquired by ESA,s Envisat on Thursday at ... of Mexico can be seen as a dark blue swirl ... oil spill five times larger than first estimated ... threatening environmental disaster. , As efforts are being made by ...
    ... A team of scientists led by the Department of Energy,s ... is publishing this week the first genome sequence of an ... in a major gap among the vertebrates sequenced to date. ... far fewer other vertebrates," said co-author Richard Harland, UC Berkeley ...
    ... 29, 2010 The American Chemical Society Green ... its 2010 research grant to Scottish chemist David ... expanding green chemistry and engineering practices in the ... $150,000-grant to further his study of the hydrogenation ...
    Cached Biology News:Oil spill in the Gulf of Mexico nears the coast 2Scientists report first genome sequence of frog 2Scientists report first genome sequence of frog 3Scientists report first genome sequence of frog 4ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist 2
    MagSi monodispers, magnetic silica particles with modified surface for SO3 coupling chemistry....
    Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
    Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
    ... repeat and SOCS box-containing protein) This polyclonal ... amino acids 75-93 and 348-368 of human ... No. 40149) can be used as a ... mouse and rat Asb-2, based on amino ...
    Biology Products: